Lacosamide 62332-0171-30
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA204974
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 50 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
62332-0171-30Selected30 TABLET, FILM COATED in 1 BOTTLE (62332-171-30)
Other packages for this product(3)
100 BLISTER PACK in 1 CARTON (62332-171-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
60 TABLET, FILM COATED in 1 BOTTLE (62332-171-60)
1000 TABLET, FILM COATED in 1 BOTTLE (62332-171-91)